Pirjo Komulainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pirjo Komulainen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Aleksi Rantanen1 shared publication
- Drake Caraker1 shared publication
- Eija Lönnroos
Institute of Public Health and Clinical Nutrition, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
1 shared publication - Harri Lindholm
Institute of Biomedicine, University of Eastern Finland School of Medicine, Kuopio, Finland
1 shared publication - Heidi Similä
Department of Smart Health, VTT Technical Research Centre of Finland Ltd., Oulu, Finland
1 shared publication - Heikki Pentikäinen
Kuopio Research Institute of Exercise Medicine, Kuopio, Finland
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e98213
The Effects of AI-Guided Exercise and a Smart Ring on Arterial Stiffness: Protocol for a Randomized Controlled Trial
Background: Cardiovascular disease (CVD) prevention is limited by the major challenge of low long-term adherence to effective lifestyle regimens. Arterial stiffness (measured by carotid-femoral pulse wave velocity [cfPWV]) and maximal cardiorespiratory fitness (measured by VO 2 max) are modifiable risk factors for CVD but require sustained lifestyle change. Wearable technology provides continuous measurement and offers a scalable platform to deliver health interventions. A combination of continuous monitoring with a wearable device and an AI-based coach personalized to individual data and preferences could be a powerful, low-barrier tool for achieving sustainable cardiovascular health benefits by directly addressing the adherence challenge. Objective: We will study the comparative effectiveness of a wearable and an interactive app-based AI coaching intervention promoting moderate exercise in improving gold-standard cfPWV and VO 2 max. This will be compared to a supervised high-intensity interval training (HIIT) group (benchmark with known benefits for VO 2 max) and a control group using only the Oura Ring (passive monitoring). We will also conduct a detailed process evaluation (structured interviews) to study the feasibility and experience of interacting with the AI coach. Methods: This randomized controlled trial will recruit 165 eligible sedentary participants aged 30 to 65 years. The co-primary outcomes, cfPWV and VO 2 max, are measured at baseline and will be repeated after 12 weeks. Participants are equally randomized into 3 groups: an AI-based coaching group (steady-state exercise), an HIIT group (supervised exercise), and a control group (usual low activity). The AI-based coaching group receives personalized guidance using large language model technology. All participants wear the Oura Ring and are blinded to the cardiovascular health metrics provided by the ring. Results: The recruitment for the study began in October 2024 and will end when 165 men and women have been recruited. Data collection for the study is scheduled to conclude in early 2026. Data management is ongoing. Conclusions: This study will evaluate whether a potentially highly scalable, AI-based coaching intervention can achieve comparable gains in cardiovascular structural health (cfPWV) and functional capacity VO 2 max relative to a resource-intensive supervised HIIT benchmark. The findings will provide essential evidence on the use of digital health tools to promote sustainable exercise adherence.
- 21 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e98213
Open AccessThe Effects of AI-Guided Exercise and a Smart Ring on Arterial Stiffness: Protocol for a Randomized Controlled Trial
Background: Cardiovascular disease (CVD) prevention is limited by the major challenge of low long-term adherence to effective lifestyle regimens. Arterial stiffness (measured by carotid-femoral pulse wave velocity [cfPWV]) and maximal cardiorespiratory fitness (measured by VO 2 max) are modifiable risk factors for CVD but require sustained lifestyle change. Wearable technology provides continuous measurement and offers a scalable platform to deliver health interventions. A combination of continuous monitoring with a wearable device and an AI-based coach personalized to individual data and preferences could be a powerful, low-barrier tool for achieving sustainable cardiovascular health benefits by directly addressing the adherence challenge. Objective: We will study the comparative effectiveness of a wearable and an interactive app-based AI coaching intervention promoting moderate exercise in improving gold-standard cfPWV and VO 2 max. This will be compared to a supervised high-intensity interval training (HIIT) group (benchmark with known benefits for VO 2 max) and a control group using only the Oura Ring (passive monitoring). We will also conduct a detailed process evaluation (structured interviews) to study the feasibility and experience of interacting with the AI coach. Methods: This randomized controlled trial will recruit 165 eligible sedentary participants aged 30 to 65 years. The co-primary outcomes, cfPWV and VO 2 max, are measured at baseline and will be repeated after 12 weeks. Participants are equally randomized into 3 groups: an AI-based coaching group (steady-state exercise), an HIIT group (supervised exercise), and a control group (usual low activity). The AI-based coaching group receives personalized guidance using large language model technology. All participants wear the Oura Ring and are blinded to the cardiovascular health metrics provided by the ring. Results: The recruitment for the study began in October 2024 and will end when 165 men and women have been recruited. Data collection for the study is scheduled to conclude in early 2026. Data management is ongoing. Conclusions: This study will evaluate whether a potentially highly scalable, AI-based coaching intervention can achieve comparable gains in cardiovascular structural health (cfPWV) and functional capacity VO 2 max relative to a resource-intensive supervised HIIT benchmark. The findings will provide essential evidence on the use of digital health tools to promote sustainable exercise adherence.
- Open Access
Measured and supervised physical exercise for older individuals with asthma, chronic obstructive pulmonary disease and obstructive sleep apnoea (MIOLI): protocol of a randomised controlled trial
Introduction: Asthma, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea (OSA) are prevalent chronic respiratory diseases associated with increased comorbidity, mortality and healthcare costs. Physical activity and exercise are widely recommended as part of treatment for these conditions, yet the specific effects of Nordic walking (NW) remain underexplored. The aims of this randomised controlled trial (RCT) are to improve physical fitness, functional capacity and respiratory health and increase regular physical activity and quality of life of older adults with asthma and/or COPD and/or OSA through a supervised 3-month group-based NW intervention combined with resistance, balance and mobility training. Methods and analysis: This single-blinded, parallel-group RCT will recruit 100 adults aged 55–80 years diagnosed with asthma and/or COPD and/or OSA in the Northern Savo region of Finland. Participants will be randomly allocated to either an intervention group or a control group. The intervention group will participate in a 12-week supervised exercise programme consisting of progressive NW sessions twice per week and resistance, balance and mobility training once per week. The primary outcome is a change in cardiorespiratory endurance. Secondary outcomes include functional capacity, physical activity level, spirometry parameters and quality of life. The control group will continue their usual physical activity and receive physical activity guidance after 12 weeks. Measurements were conducted at baseline, three and 9 months. Data will be analysed according to the intention-to-treat principle. Group differences over time will be examined using appropriate parametric or non-parametric methods depending on data distribution. Ethics and dissemination: Ethical approval was obtained from the Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area (892/13.00/2023). Findings will be disseminated through publications in peer-reviewed journals and presentations at scientific conferences. Trial registration number: The trial is registered at ISRCTN12097135 , registration date: 7 June 2024.
Open AccessMeasured and supervised physical exercise for older individuals with asthma, chronic obstructive pulmonary disease and obstructive sleep apnoea (MIOLI): protocol of a randomised controlled trial
Introduction: Asthma, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea (OSA) are prevalent chronic respiratory diseases associated with increased comorbidity, mortality and healthcare costs. Physical activity and exercise are widely recommended as part of treatment for these conditions, yet the specific effects of Nordic walking (NW) remain underexplored. The aims of this randomised controlled trial (RCT) are to improve physical fitness, functional capacity and respiratory health and increase regular physical activity and quality of life of older adults with asthma and/or COPD and/or OSA through a supervised 3-month group-based NW intervention combined with resistance, balance and mobility training. Methods and analysis: This single-blinded, parallel-group RCT will recruit 100 adults aged 55–80 years diagnosed with asthma and/or COPD and/or OSA in the Northern Savo region of Finland. Participants will be randomly allocated to either an intervention group or a control group. The intervention group will participate in a 12-week supervised exercise programme consisting of progressive NW sessions twice per week and resistance, balance and mobility training once per week. The primary outcome is a change in cardiorespiratory endurance. Secondary outcomes include functional capacity, physical activity level, spirometry parameters and quality of life. The control group will continue their usual physical activity and receive physical activity guidance after 12 weeks. Measurements were conducted at baseline, three and 9 months. Data will be analysed according to the intention-to-treat principle. Group differences over time will be examined using appropriate parametric or non-parametric methods depending on data distribution. Ethics and dissemination: Ethical approval was obtained from the Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area (892/13.00/2023). Findings will be disseminated through publications in peer-reviewed journals and presentations at scientific conferences. Trial registration number: The trial is registered at ISRCTN12097135 , registration date: 7 June 2024.